[慢性丙型肝炎：新型获批药物提高治愈率] - Suppr

Suppr

超能文献

[Chronic hepatitis C: improved cure rates with new approved medications].

作者信息

Grammatikos Georgios, Vermehren Johannes, Zeuzem Stefan

机构信息

Medizinische Klinik I, Gastroenterologie/Hepatologie Klinikum der J.W. Goethe-Universität Frankfurt, Frankfurt am Main.

出版信息

MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.

DOI:10.1007/s15006-012-0771-2

PMID:22916428

Abstract

摘要

相似文献

[Chronic hepatitis C: improved cure rates with new approved medications].

MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.

Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus.

Gastroenterology. 2012 May;142(6):1314-1323.e1. doi: 10.1053/j.gastro.2012.02.013.

[Therapy of chronic hepatitis C].

Praxis (Bern 1994). 2014 Apr 9;103(8):423-36. doi: 10.1024/1661-8157/a001618.

[Telaprevir, PEG-IFNα-2b and ribavirin combination therapy for difficult to treat patients with genotype 2 chronic hepatitis C].

Nihon Rinsho. 2015 Dec;73 Suppl 9:193-8.

[Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)].

Gastroenterol Hepatol. 2012 May;35(5):337-43. doi: 10.1016/j.gastrohep.2011.12.005. Epub 2012 Feb 19.

Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection.

Antivir Ther. 2011;16(8):1187-201. doi: 10.3851/IMP1934.

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.

Aliment Pharmacol Ther. 2012 Mar;35(6):647-62. doi: 10.1111/j.1365-2036.2012.04992.x. Epub 2012 Feb 1.

[Treatment of chronic hepatitis viral C: new associations].

Presse Med. 2013 Jun;42(6 Pt 1):977-82. doi: 10.1016/j.lpm.2012.06.019. Epub 2012 Sep 27.

Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.

J Gastrointestin Liver Dis. 2016 Mar;25(1):15-24. doi: 10.15403/jgld.2014.1121.251.a2a.

[New agents for the treatment of hepatitis C].

Enferm Infecc Microbiol Clin. 2012 Mar;30(3):147-50. doi: 10.1016/j.eimc.2011.09.012. Epub 2011 Nov 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Chronic hepatitis C: improved cure rates with new approved medications].

作者信息

Grammatikos Georgios, Vermehren Johannes, Zeuzem Stefan

机构信息

Medizinische Klinik I, Gastroenterologie/Hepatologie Klinikum der J.W. Goethe-Universität Frankfurt, Frankfurt am Main.

出版信息

MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.

DOI:10.1007/s15006-012-0771-2

PMID:22916428

Abstract

摘要

相似文献

[Chronic hepatitis C: improved cure rates with new approved medications].

MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.

Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus.

Gastroenterology. 2012 May;142(6):1314-1323.e1. doi: 10.1053/j.gastro.2012.02.013.

[Therapy of chronic hepatitis C].

Praxis (Bern 1994). 2014 Apr 9;103(8):423-36. doi: 10.1024/1661-8157/a001618.

[Telaprevir, PEG-IFNα-2b and ribavirin combination therapy for difficult to treat patients with genotype 2 chronic hepatitis C].

Nihon Rinsho. 2015 Dec;73 Suppl 9:193-8.

[Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)].

Gastroenterol Hepatol. 2012 May;35(5):337-43. doi: 10.1016/j.gastrohep.2011.12.005. Epub 2012 Feb 19.

Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection.

Antivir Ther. 2011;16(8):1187-201. doi: 10.3851/IMP1934.

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.

Aliment Pharmacol Ther. 2012 Mar;35(6):647-62. doi: 10.1111/j.1365-2036.2012.04992.x. Epub 2012 Feb 1.

[Treatment of chronic hepatitis viral C: new associations].

Presse Med. 2013 Jun;42(6 Pt 1):977-82. doi: 10.1016/j.lpm.2012.06.019. Epub 2012 Sep 27.

Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.

J Gastrointestin Liver Dis. 2016 Mar;25(1):15-24. doi: 10.15403/jgld.2014.1121.251.a2a.

[New agents for the treatment of hepatitis C].

Enferm Infecc Microbiol Clin. 2012 Mar;30(3):147-50. doi: 10.1016/j.eimc.2011.09.012. Epub 2011 Nov 25.